Clinical Trial Update: Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum

View source ↗

Summary

An ongoing University of Pittsburgh study investigating proteomics and radiomics markers for breast cancer in tissue, interstitial fluid, and serum.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Pittsburgh | Conditions: Breast Cancer | Status: RECRUITING